{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/angio-oedema-anaphylaxis/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"0124664c-1848-504a-b629-b001f3d627e7","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field d1e5e281-bfb4-40c2-9b78-7855783679d1 --><h2>Update</h2><!-- end field d1e5e281-bfb4-40c2-9b78-7855783679d1 -->","summary":null,"htmlStringContent":"<!-- begin item 2fbab3b9-893c-4f78-89f6-bbc79f5dca92 --><!-- end item 2fbab3b9-893c-4f78-89f6-bbc79f5dca92 -->","topic":{"id":"4e83ca20-0eac-5432-adf1-cb9a0716c558","topicId":"41b219ac-b62a-42d3-9d76-7b3897b21bdd","topicName":"Angio-oedema and anaphylaxis","slug":"angio-oedema-anaphylaxis","lastRevised":"Last revised in November 2018","chapters":[{"id":"f7de7576-f193-57e1-8566-52f77c198d07","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"137d41e2-195c-5b6c-a42b-a2e7774ab4c5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2d19b26a-ca5e-5feb-8be8-12f596f24eed","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"76defb8d-d620-56bc-bf42-cc72dd02704f","slug":"changes","fullItemName":"Changes"},{"id":"0124664c-1848-504a-b629-b001f3d627e7","slug":"update","fullItemName":"Update"}]},{"id":"fd3fe5d3-198d-5e2e-afaa-1de509ee14b0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8c36d3c5-8fc2-58ba-91d9-2d00dbb17605","slug":"goals","fullItemName":"Goals"},{"id":"dbfbfeb0-8ad4-5a3d-8458-06af672eab12","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bbc732dc-6fbc-5902-a5bf-890776f1df44","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"49ccfcd1-6054-5eac-b6a2-c85eb605ecfd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c97855a-e489-54e6-8f4b-28dbc050951e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"71eafab9-7c66-5e57-aa08-197ad09eb9e7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c158e9f-bfe1-56ea-a1fe-97e4da83b82d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ed1b7bb1-0232-5ceb-991c-c936ac2a3086","slug":"definition","fullItemName":"Definition"},{"id":"ac67665b-2b88-5df8-9a70-cc35f96825ae","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"a4358430-db1f-55c2-9d68-6ce8076813ba","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7ebee135-258e-58ce-a91e-947b8a2f9563","slug":"complications","fullItemName":"Complications"},{"id":"7c2a6ca1-0f6a-5a40-bc06-dbbbf95c57c1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4b20303c-5905-594a-a8c6-4f85e46cf3f9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"005b06b8-18c4-569f-b1b3-3c6d1218ddf7","slug":"diagnosis-of-angio-oedema","fullItemName":"Diagnosis of angio-oedema"},{"id":"682e56cf-4c4d-5736-8db7-4cd4bfcab6e2","slug":"assessing-the-cause-of-angio-oedema","fullItemName":"Assessing the cause of angio-oedema"},{"id":"bf860a63-b9a4-5c14-bf1b-46423d3df7ad","slug":"diagnosis-of-anaphylaxis","fullItemName":"Diagnosis of anaphylaxis"},{"id":"fab5c932-e15e-5303-99e9-48f7d2e415b4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1c5f38ef-17d4-569d-ad54-b819fd953d6c","fullItemName":"Management","slug":"management","subChapters":[{"id":"654a5e70-49b7-58b4-b976-7e94c44b3074","slug":"angio-oedema-without-anaphylaxis","fullItemName":"Scenario: Angio-oedema without anaphylaxis"},{"id":"5759117d-4bde-53b6-b78d-7885ccbf431e","slug":"anaphylaxis-with-or-without-angio-oedema","fullItemName":"Scenario: Anaphylaxis with or without angio-oedema"}]},{"id":"6f94e28f-193d-587a-a11a-0a05a1be037f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b59ab8fd-de1f-555e-946a-c3a53b918da4","slug":"emergency-drug-doses","fullItemName":"Emergency drug doses"},{"id":"69e007b8-2046-5946-a7b5-de8f1bb9de9f","slug":"non-sedating-antihistamines-no-airway-involvement","fullItemName":"Non-sedating antihistamines (no airway involvement)"},{"id":"dac089ca-3b63-536d-9737-82806f78b88e","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"7ead2f48-36a4-5547-8570-4d4ab5898a73","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a7653e34-460d-5737-b0c3-264ecc26dc68","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a713ee82-3188-50ea-a2bc-a562abd97621","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7421fd02-2e34-5526-bd39-905aa772f800","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d24df800-eddc-5bf3-bea0-d556b5e01aed","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"af27ed5c-0853-5d16-91a4-5e5878ee9209","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f7640a76-8bc4-569e-8b82-717e6bd5f041","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b4778aa1-f37d-574f-8514-47ac86bf2c2e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2d19b26a-ca5e-5feb-8be8-12f596f24eed","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"fe115c54-f80b-5381-bd70-b6f111ac9fbd","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field be0bedbe-e3c7-4e93-9cf9-52babc5e24b6 --><h3>New evidence</h3><!-- end field be0bedbe-e3c7-4e93-9cf9-52babc5e24b6 -->","summary":null,"htmlStringContent":"<!-- begin item b8e998f9-e72a-4e11-ad67-4704b454b498 --><!-- begin field 2b5bfbc4-614e-4ebe-a1ce-fd4fafbd113b --><h3>Evidence-based guidelines</h3><!-- end field 2b5bfbc4-614e-4ebe-a1ce-fd4fafbd113b --><!-- begin field 76014081-4fc7-4e00-aa7c-8d64594ae324 --><ul><li>DH (2017) <em>Guidance on the use of adrenaline auto-injectors in schools</em>. Department of Health <a data-hyperlink-id=\"3cda3971-55cb-425c-a471-a98e016f8a0b\" href=\"http://www.dh.gov.uk/\">www.dh.gov.uk</a> [<a data-hyperlink-id=\"b50863e7-a8b0-433a-853b-a98e016f8a35\" href=\"https://www.gov.uk/government/publications/using-emergency-adrenaline-auto-injectors-in-schools\">Free Full-text</a>]</li></ul><!-- end field 76014081-4fc7-4e00-aa7c-8d64594ae324 --><!-- begin field 73e802a9-e0a1-4a4b-b5ab-c5da24ff10f9 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 73e802a9-e0a1-4a4b-b5ab-c5da24ff10f9 --><!-- begin field 7104c3d0-109a-40db-919b-a5c3b1afcda2 --><p>No new HTAs since 1 May 2017.</p><!-- end field 7104c3d0-109a-40db-919b-a5c3b1afcda2 --><!-- begin field f756b3c7-f9f6-4239-a6eb-69588ce091c9 --><h3>Economic appraisals</h3><!-- end field f756b3c7-f9f6-4239-a6eb-69588ce091c9 --><!-- begin field 3031d6c5-6580-4695-960e-752a52c2fa66 --><p>No new economic appraisals relevant to England since 1 May 2017.</p><!-- end field 3031d6c5-6580-4695-960e-752a52c2fa66 --><!-- begin field 9077f8a0-b345-43f1-91b9-b8e54045ac48 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 9077f8a0-b345-43f1-91b9-b8e54045ac48 --><!-- begin field bdef53c3-6ec3-4700-af6e-b22484c186f2 --><p>No new systematic reviews published since 1 May 2017.</p><!-- end field bdef53c3-6ec3-4700-af6e-b22484c186f2 --><!-- begin field 145cc81b-759c-467c-b084-53e0a7fcfc4b --><h3>Primary evidence</h3><!-- end field 145cc81b-759c-467c-b084-53e0a7fcfc4b --><!-- begin field 9c275604-5bc5-42bc-b437-fd60df990c16 --><p>No new randomized controlled trials published in the major journals since 1 May 2017.</p><!-- end field 9c275604-5bc5-42bc-b437-fd60df990c16 --><!-- end item b8e998f9-e72a-4e11-ad67-4704b454b498 -->","subChapters":[]},{"id":"cdcdb8b8-7244-5c4a-acc9-61b81347b5b1","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field b07f9404-69c7-4f3f-b89b-0427d9ac72bd --><h3>New policies</h3><!-- end field b07f9404-69c7-4f3f-b89b-0427d9ac72bd -->","summary":null,"htmlStringContent":"<!-- begin item 1257e952-e621-45f4-bfbd-daacc7468af7 --><!-- begin field 261af61e-9c2a-4f9e-b281-56b1c6083d97 --><p>No new national policies or guidelines since 1 May 2017.</p><!-- end field 261af61e-9c2a-4f9e-b281-56b1c6083d97 --><!-- end item 1257e952-e621-45f4-bfbd-daacc7468af7 -->","subChapters":[]},{"id":"901c25f4-787b-50de-a00a-fa0d15dad07f","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field d4d387b5-b718-46bb-83a0-d65b24b74723 --><h3>New safety alerts</h3><!-- end field d4d387b5-b718-46bb-83a0-d65b24b74723 -->","summary":null,"htmlStringContent":"<!-- begin item b6606619-f508-4f54-9661-551aa8d30eec --><!-- begin field 24874bae-258d-4aff-abb0-bab613fb7390 --><p>No new safety alerts since 1 May 2017.</p><!-- end field 24874bae-258d-4aff-abb0-bab613fb7390 --><!-- end item b6606619-f508-4f54-9661-551aa8d30eec -->","subChapters":[]},{"id":"38dbc0bc-4f50-5105-8459-d961fdf14b9d","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 7f2069b3-e4b1-4330-bff4-a16e0612b095 --><h3>Changes in product availability</h3><!-- end field 7f2069b3-e4b1-4330-bff4-a16e0612b095 -->","summary":null,"htmlStringContent":"<!-- begin item a401e998-a1cf-441f-8b6e-ed6c84c8047e --><!-- begin field 5d09cd0a-8e27-459a-a51d-ae135a3270af --><p>No changes in product availability since 1 May 2017.</p><!-- end field 5d09cd0a-8e27-459a-a51d-ae135a3270af --><!-- end item a401e998-a1cf-441f-8b6e-ed6c84c8047e -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}